Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. Benzinga · Dec 4, 2024
Cronos Group (CRON) vs. MariMed (MRMD): Which Stock Are Investors Buying? With evolving food consumption trends, favorable government policies and funding, and the adoption of cutting-edge technologies, the agricultural industry is well-placed to experience significant growth in the long run. So, let’s compare prominent agriculture stocks Cronos Group (CRON) and MariMed (MRMD) to identify which is gaining immense popularity among investors.… StockNews.com · Jun 27, 2023
MariMed's Q3 Financial Results, Revenue Increases 3% Sequentially To $33.9M MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022. Benzinga · Nov 7, 2022
MariMed Enriches Betty's Eddies Line With Cannabis Chews To Empower Libido, Reduce Stress, Improve Sleep & More MariMed, Inc (CSE: MRMD), (OTCQX: MRMD) added new products to its top-selling Betty’s Eddies all-natural cannabis fruit chews brand. Benzinga · Oct 25, 2022
What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark. Benzinga · Oct 22, 2022
EXCLUSIVE: How To Conquer The Midwest? 4Front, Pharmacann & Marimed Execs Discuss At Benzinga Cannabis Conference Jon Levine, president of Marimed Inc., Brett Novey, CEO of Pharmacann and Andrew Thut, CIO of 4Front Ventures, operators in the Midwest and across the country, joined Barbara Webb, partner of MGO, and Steve Miles, CEO of Sharp Capi Benzinga · Sep 14, 2022
MariMed Inc.: Existing Assets Have The Ability To Generate Over $350 million In Revenue Over Time On August 8, MariMed, Inc. (OTC: MRMD) delivered second quarter 2022 financial results near the beginning of U.S. cannabis earnings season. Benzinga · Aug 26, 2022
EXCLUSIVE: Dartmouth Engineering Students Conduct First-Ever Study On Energy Efficiency In Cannabis Cultivation Dartmouth's Thayer School of Engineering and Arthur L. Irving Institute for Energy and Society announced the results of a first-of-its-kind independent study on energy efficiency in the cannabis industry. Benzinga · Aug 3, 2022
MariMed Inc: Among A Select Few U.S. Cannabis Operators Generating Free Cash Flow And Positive Net Income In a world where many U.S. cannabis multi-state operators (MSOs) laud the their ability to generate positive Adjusted EBITDA, MariMed, Inc. (OTC: MRMD) goes a couple of steps further. Benzinga · Jul 19, 2022
MariMed To Launch Betty's Eddies Brand Into Maine Adult-Use Cannabis Marketplace MariMed, Inc. (OTCQX: MRMD) entered into a licensing agreement with East Coast Cannabis Company. Benzinga · Jun 29, 2022
MariMed Awarded Medical Cannabis Dispensary License In Ohio MariMed Inc. (OTCQX: MRMD) had been awarded a provisional dispensary license by the Ohio Board of Pharmacy. Benzinga · May 18, 2022
MariMed Reports Strong Q1, Provides 2022 Financial Guidance MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2022. Benzinga · May 11, 2022
MariMed Closes Acquisition Of Illinois Craft Cannabis License, Here Is What You Need To Know MariMed, Inc. (OTCQX: MRMD) has closed its acquisition of Green Growth Group, Inc. Benzinga · May 5, 2022
Benzinga · Apr 29, 2022 MariMed Completes Acquisition Of Kind Therapeutics USA, A Maryland Vertically Integrated Cannabis Business MariMed Inc. (OTCQX: MRMD) completed the acquisition of Kind Therapeutics U.S.A., LLC.
Benzinga · Apr 22, 2022 Cannabis Stock Gainers And Losers From April 22, 2022 GAINERS: MariMed (OTC:MRMD) shares closed up 5.59% at $0.72
Benzinga · Apr 21, 2022 EXCLUSIVE: Why Cannabis Industry Consolidation 'In The Foreseeable Future' Is Most Likely To Continue Growth can come through the acquisition of businesses at the grassroots level. “We are buying to continue to grow.”
Benzinga · Apr 20, 2022 EXCLUSIVE: MariMed's CEO On 'Making Love To The Plant' MariMed Inc. (OTCQX: MRMD) is hoping to expand its presence into seven more states in the next 18 months.
Benzinga · Apr 20, 2022 Last-Minute Ideas For 4/20: 40 Products to Elevate Your Cannabis Day Celebrations Every cannabis consumer’s favorite holiday is here. April 20th, or 4/20 as it’s called, is a holiday all about celebrating the plant, educating others on the benefits of cannabis, and most importantly: consuming cannabis.
Benzinga · Apr 14, 2022 MariMed Receives Maryland State Approval For Transfer Of Ownership Of Kind Therapeutics USA Maryland Medical Cannabis Commission has approved the transfer of 100% of the ownership of Kind Therapeutics U.S.A., LLC, to MariMed Inc. (OTCQX: MRMD)
Benzinga · Apr 11, 2022 MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing On CSE MariMed, Inc. (OTCQX:MRMD) has filed a preliminary non-offering long form prospectus with the securities regulatory authorities in the provinces of Ontario and British Columbia. No securities are being sold pursuant to the prospectus and no proceeds are being raised.
StockNews.com · Apr 1, 2022 4 Penny Stocks with Over 155% Upside Potential, According to Wall Street After a tumultuous start to the year, the stock market appears to have stabilized somewhat. And with talks between Russia and Ukraine progressing, the stock market may bounce back on any positive developments. So, we think it could be wise to add penny stocks MariMed (MRMD), Exela Technologies (XELA), Inuvo…
Benzinga · Mar 16, 2022 MariMed Doubles Full Year Revenue And Adjusted EBITDA, Reports Q4 & Full Year Earnings MariMed (OTCQX: MRMD), a leading multi-state cannabis operator, announced its financial and operating results for the fourth quarter and full year ended December 31, 2021.
Benzinga · Mar 10, 2022 MariMed Launches Vibations: High + Energy Cannabis-Infused Drink Mix MariMed, Inc. (OTCQX: MRMD) launched Vibations: High + Energy, an all-natural, full-spectrum cannabis drink mix that provides focus and energy for the mind and body.
Benzinga · Mar 8, 2022 MariMed Expands Massachusetts Retail Footprint With Acquisition Of Cannabis Dispensary In Beverly MariMed, Inc. (OTCQX: MRMD) has signed a definitive agreement to acquire a provisional dispensary license from Green House Naturals, LLC.